A detailed history of Fortitude Family Office, LLC transactions in Moderna, Inc. stock. As of the latest transaction made, Fortitude Family Office, LLC holds 124 shares of MRNA stock, worth $4,976. This represents 0.0% of its overall portfolio holdings.

Number of Shares
124
Previous 28 342.86%
Holding current value
$4,976
Previous $3.33 Million 149.23%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024

BUY
$63.64 - $125.14 $6,109 - $12,013
96 Added 342.86%
124 $8.29 Million
Q2 2024

Jul 10, 2024

BUY
$101.21 - $166.61 $2,226 - $3,665
22 Added 366.67%
28 $3.33 Million
Q4 2023

Jan 12, 2024

BUY
$69.51 - $104.43 $417 - $626
6 New
6 $597,000

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $15.7B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Fortitude Family Office, LLC Portfolio

Follow Fortitude Family Office, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fortitude Family Office, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fortitude Family Office, LLC with notifications on news.